Get the Stockscreener App
33.57
2.01%
-0.69
After Hours:
33.57
Rxsight Inc stock is traded at $33.57, with a volume of 329.89K.
It is down -2.01% in the last 24 hours and down -5.17% over the past month.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
See More
Previous Close:
$34.26
Open:
$34.22
24h Volume:
329.89K
Relative Volume:
0.46
Market Cap:
$1.35B
Revenue:
$128.29M
Net Income/Loss:
$-30.69M
P/E Ratio:
-40.94
EPS:
-0.82
Net Cash Flow:
$-27.17M
1W Performance:
+2.16%
1M Performance:
-5.17%
6M Performance:
-29.84%
1Y Performance:
-29.31%
1-Day Range:
$33.57
$34.64
1-Week Range:
$32.00
$34.71
52-Week Range:
$26.29
$66.54
Rxsight Inc Stock (RXST) Company Profile
Name
Rxsight Inc
Sector
Industry
Phone
949-521-7822
Address
100 COLUMBIA STREET, ALISO VIEJO
Compare RXST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
33.57 | 1.35B | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
128.22 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.02 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
396.07 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.99 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-24 | Downgrade | Stifel | Buy → Hold |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | UBS | Buy |
| Oct-29-24 | Initiated | Jefferies | Buy |
| Aug-20-24 | Reiterated | Needham | Buy |
| Aug-06-24 | Reiterated | Needham | Buy |
| May-07-24 | Reiterated | BTIG Research | Buy |
| Dec-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Initiated | Morgan Stanley | Overweight |
| Apr-13-23 | Initiated | Oppenheimer | Outperform |
| Dec-12-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-08-22 | Initiated | Needham | Buy |
View All
Rxsight Inc Stock (RXST) Latest News
Potential Price Increase for RxSight Inc (RXST) After Recent Insider Activity - Knox Daily
Ready to Jump After Recent Trade: RxSight Inc (RXST) - SETE News
This RxSight Insider Reduced Their Stake By 18% - Simply Wall St
RxSight Inc (RXST): A New Perspective - Stocks Register
RxSight director sells $108,618 in common stock - MSN
(RXST) Technical Pivots with Risk Controls - Stock Traders Daily
Shweta Maniar Sells 3,519 Shares of RxSight, Inc. (NASDAQ:RXST) Stock - MarketBeat
RxSight director sells $108,618 in common stock By Investing.com - Investing.com UK
Midday Stock Roundup: FivePoint Holdings Jumps 36% - Orange County Business Journal
rXsight director Corley Jesse Anderson acquires $100,004 in shares - MSN
RxSight, Inc. (NASDAQ:RXST) Position Reduced by Sara Bay Financial - MarketBeat
Insider Buying: RxSight, Inc. (NASDAQ:RXST) Director Buys 1,443 Shares of Stock - MarketBeat
rXsight director Corley Jesse Anderson acquires $100,004 in shares By Investing.com - Investing.com South Africa
RxSight price target lowered to $43 from $66 at Needham - Yahoo Finance
(RXST) Long Term Investment Analysis - Stock Traders Daily
RxSight (NASDAQ:RXST) Stock Price Down 3.9%Here's Why - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Receives $58.13 Average Price Target from Analysts - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
RxSight Inc (RXST) Shares Down 4.25% on Jan 14 - GuruFocus.com
RxSight, Inc. (NASDAQ:RXST) Shares Bought by JPMorgan Chase & Co. - Defense World
RxSight (NASDAQ:RXST) Price Target Lowered to $35.00 at Stifel Nicolaus - Defense World
RxSight (NASDAQ:RXST) Receives “Buy” Rating from Needham & Company LLC - Defense World
RxSight (NASDAQ:RXST) Price Target Lowered to $40.00 at Wells Fargo & Company - Defense World
Wells Fargo & Company Lowers RxSight (NASDAQ:RXST) Price Target to $40.00 - MarketBeat
Stifel cuts RxSight shares target, cautious on competition and international expansion efforts By Investing.com - Investing.com South Africa
Ron Kurtz: Revolutionizing Cataract Surgery - Orange County Business Journal
RxSight (NASDAQ:RXST) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Stifel cuts RxSight shares target, cautious on competition and international expansion efforts - Investing.com India
RxSight Inc. (RXST) PT Lowered to $35 at Stifel Following 'Somewhat Soft' 4Q24 Preliminary Results - StreetInsider.com
RxSight Becomes Oversold (RXST) - Nasdaq
Stifel Nicolaus Lowers RxSight (NASDAQ:RXST) Price Target to $35.00 - MarketBeat
RxSight shares drop by 21% following disappointing revenue forecast - Investing.com Canada
Needham & Company LLC Reiterates "Buy" Rating for RxSight (NASDAQ:RXST) - MarketBeat
RxSight shares reiterated at Buy at Needham following guidance By Investing.com - Investing.com Australia
RxSight shares reiterated at Buy at Needham following guidance - Investing.com
Needham Reiterates Buy Rating on RxSight Inc. (RXST) - StreetInsider.com
Rxsight, Inc. Provides Earnings Guidance for Fourth Quarter of 2024, Full Year 2024 and Full Year 2025 - Marketscreener.com
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance - Marketscreener.com
RxSight, Inc. Announces Preliminary Unaudited Fourth - GlobeNewswire
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and - The Bakersfield Californian
RxSight Delivers 57% Revenue Surge to $140M as Light Adjustable Lens Adoption Soars - StockTitan
RxSight (NASDAQ:RXST) Reaches New 1-Year LowHere's What Happened - MarketBeat
RxSight stock touches 52-week low at $33 amid market shifts By Investing.com - Investing.com South Africa
RxSight stock touches 52-week low at $33 amid market shifts - Investing.com Australia
Rxsight Inc Stock (RXST) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.14%
2.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):